Biosimilarity isn’t discovered. It’s engineered.
Precision in every molecule.
A pure-play biosimilar company with an international track record.
Built to accelerate biosimilars development – cell to sell.
Approved biosimilars
2
Years biologics expertise
12+
Regulatory standards
Global GMP · FDA · EMA · ICH
Operating from Zug
Switzerland
Commercial Reach – Global
EU · US · Emerging markets
WHAT WE DO
We produce impact-driven biosimilars. From concept to commercial supply.
We know as programs pass through various stages of development, they need specific experience and focused attention.
We don't just develop molecules.
We manage the interfaces.
We know
Our goal
as programs pass
through various stages
of development, they need
specific experience and focused attention.
We know as programs pass through various stages of development, they need specific experience and focused attention.
We don't just develop molecules.
We manage the interfaces.
To keep every program seemlessly moving as one system, from concept to commercial supply.
Our goal is to keep every program seemlessly moving as one system, from concept to commercial supply.
Full biosimilar lifecycle.
One global development strategy.
Swiss engineered, supplied globally
Why partners trust us.
key pillars
A foundation for reach
We build every program to be regulatory-ready across geographies, giving our commercial partners the fastest possible path to their markets.
A clean track record
Development pathways built on regulatory rigor, so partners commercialize with certainty. Every product we’ve brought to approval cleared without regulatory objections.
Built for continuity
Coordinated manufacturing and distribution networks designed to keep supply steady, even at scale.
One point, full orchestration
A single accountable partner coordinating best-in-class development, manufacturing and commercial supply — so partners can focus on getting products to market.
We cover the full biosimilar lifecycle
A strong intellectual property landscape assessment guides development, differentiation and long-term value creation.
Development
Designed for scale from day one
GMP manufacturing built for compliance
Tech transfer managed end-to-end
Clinical strategy, study planning, execution & reporting
Innovation-led device development focused on usability & access
Regulatory
One unified regulatory strategy
Dossier built for global submission
Inspection readiness from the start
Commercial supply
Supply continuity built into the program
Launch planning across global markets
Operational risk managed proactively
Lifecycle management
Post-approval changes handled in-house
Label extensions and process updates
Accountable long after launch
Biosimilars pipeline
Meet the team of experts behind every program
Deep expertise. Lean by intention.
Insights
Want to move Biosimilars from lab to patient access – from development to in market
If you are motivated by complex challenges and meaningful work, we invite you to join us.
Our people are at the heart
of our success.
We bring together scientists, engineers, quality experts, and business professionals who share a commitment to excellence and patient impact.
The right partner changes everything
Our partnerships are built on trust, ownership, and long-term commitment.
